Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Phelan CM., Kuchenbaecker KB., Tyrer JP., Kar SP., Lawrenson K., Winham SJ., Dennis J., Pirie A., Riggan MJ., Chornokur G., Earp MA., Lyra PC., Lee JM., Coetzee S., Beesley J., McGuffog L., Soucy P., Dicks E., Lee A., Barrowdale D., Lecarpentier J., Leslie G., Aalfs CM., Aben KKH., Adams M., Adlard J., Andrulis IL., Anton-Culver H., Antonenkova N., AOCS study group None., Aravantinos G., Arnold N., Arun BK., Arver B., Azzollini J., Balmaña J., Banerjee SN., Barjhoux L., Barkardottir RB., Bean Y., Beckmann MW., Beeghly-Fadiel A., Benitez J., Bermisheva M., Bernardini MQ., Birrer MJ., Bjorge L., Black A., Blankstein K., Blok MJ., Bodelon C., Bogdanova N., Bojesen A., Bonanni B., Borg Å., Bradbury AR., Brenton JD., Brewer C., Brinton L., Broberg P., Brooks-Wilson A., Bruinsma F., Brunet J., Buecher B., Butzow R., Buys SS., Caldes T., Caligo MA., Campbell I., Cannioto R., Carney ME., Cescon T., Chan SB., Chang-Claude J., Chanock S., Chen XQ., Chiew Y-E., Chiquette J., Chung WK., Claes KBM., Conner T., Cook LS., Cook J., Cramer DW., Cunningham JM., D'Aloisio AA., Daly MB., Damiola F., Damirovna SD., Dansonka-Mieszkowska A., Dao F., Davidson R., DeFazio A., Delnatte C., Doheny KF., Diez O., Ding YC., Doherty JA., Domchek SM., Dorfling CM., Dörk T., Dossus L., Duran M., Dürst M., Dworniczak B., Eccles D., Edwards T., Eeles R., Eilber U., Ejlertsen B., Ekici AB., Ellis S., Elvira M., EMBRACE Study None., Eng KH., Engel C., Evans DG., Fasching PA., Ferguson S., Ferrer SF., Flanagan JM., Fogarty ZC., Fortner RT., Fostira F., Foulkes WD., Fountzilas G., Fridley BL., Friebel TM., Friedman E., Frost D., Ganz PA., Garber J., García MJ., Garcia-Barberan V., Gehrig A., GEMO Study Collaborators None., Gentry-Maharaj A., Gerdes A-M., Giles GG., Glasspool R., Glendon G., Godwin AK., Goldgar DE., Goranova T., Gore M., Greene MH., Gronwald J., Gruber S., Hahnen E., Haiman CA., Håkansson N., Hamann U., Hansen TVO., Harrington PA., Harris HR., Hauke J., HEBON Study None., Hein A., Henderson A., Hildebrandt MAT., Hillemanns P., Hodgson S., Høgdall CK., Høgdall E., Hogervorst FBL., Holland H., Hooning MJ., Hosking K., Huang R-Y., Hulick PJ., Hung J., Hunter DJ., Huntsman DG., Huzarski T., Imyanitov EN., Isaacs C., Iversen ES., Izatt L., Izquierdo A., Jakubowska A., James P., Janavicius R., Jernetz M., Jensen A., Jensen UB., John EM., Johnatty S., Jones ME., Kannisto P., Karlan BY., Karnezis A., Kast K., KConFab Investigators None., Kennedy CJ., Khusnutdinova E., Kiemeney LA., Kiiski JI., Kim S-W., Kjaer SK., Köbel M., Kopperud RK., Kruse TA., Kupryjanczyk J., Kwong A., Laitman Y., Lambrechts D., Larrañaga N., Larson MC., Lazaro C., Le ND., Le Marchand L., Lee JW., Lele SB., Leminen A., Leroux D., Lester J., Lesueur F., Levine DA., Liang D., Liebrich C., Lilyquist J., Lipworth L., Lissowska J., Lu KH., Lubinński J., Luccarini C., Lundvall L., Mai PL., Mendoza-Fandiño G., Manoukian S., Massuger LFAG., May T., Mazoyer S., McAlpine JN., McGuire V., McLaughlin JR., McNeish I., Meijers-Heijboer H., Meindl A., Menon U., Mensenkamp AR., Merritt MA., Milne RL., Mitchell G., Modugno F., Moes-Sosnowska J., Moffitt M., Montagna M., Moysich KB., Mulligan AM., Musinsky J., Nathanson KL., Nedergaard L., Ness RB., Neuhausen SL., Nevanlinna H., Niederacher D., Nussbaum RL., Odunsi K., Olah E., Olopade OI., Olsson H., Olswold C., O'Malley DM., Ong K-R., Onland-Moret NC., OPAL study group None., Orr N., Orsulic S., Osorio A., Palli D., Papi L., Park-Simon T-W., Paul J., Pearce CL., Pedersen IS., Peeters PHM., Peissel B., Peixoto A., Pejovic T., Pelttari LM., Permuth JB., Peterlongo P., Pezzani L., Pfeiler G., Phillips K-A., Piedmonte M., Pike MC., Piskorz AM., Poblete SR., Pocza T., Poole EM., Poppe B., Porteous ME., Prieur F., Prokofyeva D., Pugh E., Pujana MA., Pujol P., Radice P., Rantala J., Rappaport-Fuerhauser C., Rennert G., Rhiem K., Rice P., Richardson A., Robson M., Rodriguez GC., Rodríguez-Antona C., Romm J., Rookus MA., Rossing MA., Rothstein JH., Rudolph A., Runnebaum IB., Salvesen HB., Sandler DP., Schoemaker MJ., Senter L., Setiawan VW., Severi G., Sharma P., Shelford T., Siddiqui N., Side LE., Sieh W., Singer CF., Sobol H., Song H., Southey MC., Spurdle AB., Stadler Z., Steinemann D., Stoppa-Lyonnet D., Sucheston-Campbell LE., Sukiennicki G., Sutphen R., Sutter C., Swerdlow AJ., Szabo CI., Szafron L., Tan YY., Taylor JA., Tea M-K., Teixeira MR., Teo S-H., Terry KL., Thompson PJ., Thomsen LCV., Thull DL., Tihomirova L., Tinker AV., Tischkowitz M., Tognazzo S., Toland AE., Tone A., Trabert B., Travis RC., Trichopoulou A., Tung N., Tworoger SS., van Altena AM., Van Den Berg D., van der Hout AH., van der Luijt RB., Van Heetvelde M., Van Nieuwenhuysen E., van Rensburg EJ., Vanderstichele A., Varon-Mateeva R., Vega A., Edwards DV., Vergote I., Vierkant RA., Vijai J., Vratimos A., Walker L., Walsh C., Wand D., Wang-Gohrke S., Wappenschmidt B., Webb PM., Weinberg CR., Weitzel JN., Wentzensen N., Whittemore AS., Wijnen JT., Wilkens LR., Wolk A., Woo M., Wu X., Wu AH., Yang H., Yannoukakos D., Ziogas A., Zorn KK., Narod SA., Easton DF., Amos CI., Schildkraut JM., Ramus SJ., Ottini L., Goodman MT., Park SK., Kelemen LE., Risch HA., Thomassen M., Offit K., Simard J., Schmutzler RK., Hazelett D., Monteiro AN., Couch FJ., Berchuck A., Chenevix-Trench G., Goode EL., Sellers TA., Gayther SA., Antoniou AC., Pharoah PDP.
To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC cases and 40,941 controls. We identified nine new susceptibility loci for different EOC histotypes: six for serous EOC histotypes (3q28, 4q32.3, 8q21.11, 10q24.33, 18q11.2 and 22q12.1), two for mucinous EOC (3q22.3 and 9q31.1) and one for endometrioid EOC (5q12.3). We then performed meta-analysis on the results for high-grade serous ovarian cancer with the results from analysis of 31,448 BRCA1 and BRCA2 mutation carriers, including 3,887 mutation carriers with EOC. This identified three additional susceptibility loci at 2q13, 8q24.1 and 12q24.31. Integrated analyses of genes and regulatory biofeatures at each locus predicted candidate susceptibility genes, including OBFC1, a new candidate susceptibility gene for low-grade and borderline serous EOC.